Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,287 | 809 | 60.5% |
| Consulting Fee | $4,800 | 2 | 14.3% |
| Honoraria | $3,000 | 1 | 8.9% |
| Travel and Lodging | $2,787 | 5 | 8.3% |
| Unspecified | $2,387 | 1 | 7.1% |
| Education | $265.16 | 4 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.20 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $5,917 | 21 | $0 (2023) |
| EPI Health, LLC | $4,197 | 16 | $0 (2021) |
| ABBVIE INC. | $4,056 | 162 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $2,980 | 43 | $0 (2024) |
| Eli Lilly and Company | $2,387 | 1 | $0 (2024) |
| Galderma Laboratories, L.P. | $2,151 | 85 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,905 | 81 | $0 (2024) |
| GENZYME CORPORATION | $1,336 | 29 | $0 (2024) |
| LEO Pharma Inc. | $1,196 | 78 | $0 (2024) |
| Incyte Corporation | $1,176 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,178 | 130 | Eli Lilly and Company ($2,387) |
| 2023 | $3,222 | 133 | AbbVie Inc. ($829.12) |
| 2022 | $2,831 | 107 | Incyte Corporation ($795.92) |
| 2021 | $2,524 | 127 | SUN PHARMACEUTICAL INDUSTRIES INC. ($538.05) |
| 2020 | $1,736 | 95 | LEO Pharma Inc. ($298.31) |
| 2019 | $7,849 | 83 | EPI Health, LLC ($4,103) |
| 2018 | $7,653 | 76 | Janssen Biotech, Inc. ($5,553) |
| 2017 | $2,555 | 72 | AbbVie, Inc. ($480.41) |
All Payment Transactions
823 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.58 | General |
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.96 | General |
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $44.06 | General |
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: DERMATOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: DERMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) | Eli Lilly and Company | $2,387 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 790 | 1,845 | $291,864 | $184,830 |
| 2022 | 15 | 579 | 1,087 | $142,217 | $90,046 |
| 2021 | 14 | 422 | 879 | $106,183 | $69,105 |
| 2020 | 10 | 349 | 587 | $71,821 | $42,237 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 430 | $71,059 | $45,161 | 63.6% |
| 96922 | Treatment of inflammatory skin disease using laser, more than 500.0 sq cm | Office | 2023 | 13 | 115 | $35,039 | $24,268 | 69.3% |
| 17107 | Destruction of birthmark, 10.0-50.0 sq cm | Office | 2023 | 35 | 53 | $30,882 | $20,649 | 66.9% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 16 | 98 | $27,439 | $17,715 | 64.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $26,893 | $15,524 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 156 | $18,428 | $11,814 | 64.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 74 | 117 | $16,278 | $9,346 | 57.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 28 | 46 | $10,033 | $6,811 | 67.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 47 | 73 | $11,112 | $6,809 | 61.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 49 | 114 | $9,884 | $5,727 | 57.9% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 11 | 14 | $6,689 | $4,291 | 64.2% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 20 | 35 | $6,195 | $3,969 | 64.1% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 11 | 12 | $4,797 | $3,134 | 65.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 41 | 63 | $5,602 | $2,798 | 50.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 25 | 54 | $3,775 | $2,458 | 65.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $3,816 | $2,152 | 56.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 34 | 225 | $2,182 | $1,383 | 63.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 19 | $1,451 | $767.51 | 52.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 66 | $307.62 | $54.25 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 201 | $32,150 | $21,053 | 65.5% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2022 | 106 | 166 | $17,697 | $13,611 | 76.9% |
| 17107 | Destruction of birthmark, 10.0-50.0 sq cm | Office | 2022 | 22 | 30 | $16,800 | $11,264 | 67.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $13,730 | $8,266 | 60.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 91 | $10,465 | $7,088 | 67.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 51 | 75 | $10,125 | $5,837 | 57.6% |
About Dr. Yen Wang, M.D
Dr. Yen Wang, M.D is a Dermatology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1013206945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yen Wang, M.D has received a total of $33,548 in payments from pharmaceutical and medical device companies, with $5,178 received in 2024. These payments were reported across 823 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($20,287).
As a Medicare-enrolled provider, Wang has provided services to 2,140 Medicare beneficiaries, totaling 4,398 services with total Medicare billing of $386,218. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Los Angeles, CA
- Active Since 03/31/2011
- Last Updated 11/20/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013206945
Products in Payments
- Tremfya (Drug) $5,575
- Sitavig (Drug) $4,163
- TALTZ (Drug) $2,624
- SILIQ (Drug) $2,177
- DUPIXENT (Biological) $1,489
- SKYRIZI (Biological) $1,132
- ENSTILAR (Drug) $1,131
- Humira (Biological) $1,120
- RINVOQ (Biological) $1,096
- OPZELURA (Drug) $1,086
- EUCRISA (Drug) $703.08
- Winlevi (Drug) $579.98
- ILUMYA (Biological) $574.05
- ORACEA (Drug) $519.55
- DUOBRII (Drug) $505.81
- Otezla (Drug) $453.30
- VTAMA (Drug) $451.94
- STELARA (Biological) $350.21
- DORYX (Drug) $323.53
- Ilumya (Biological) $307.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Los Angeles
Christopher Ho, Md, MD
Dermatology — Payments: $929,207
Dr. Howard Sofen, M.d, M.D
Dermatology — Payments: $654,301
Jennifer Hsiao, M.d, M.D
Dermatology — Payments: $400,325
Dr. Pearl Grimes, Md, MD
Dermatology — Payments: $358,500
Derek Jones, Md, MD
Dermatology — Payments: $316,086
Rebecca Fitzgerald, M.d, M.D
Dermatology — Payments: $281,818